GSA Capital Partners’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

GSA Capital Partners’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-22,152	Closed	-$199K	–	2161
2016 Q3	$199K	Buy	+22,152	New	+$158K	0.01%	1612
2016 Q1	–	Sell	-20,886	Closed	-$109K	–	2133
2015 Q4	$109K	Buy	+20,886	New	+$121K	0.01%	1727

GSA Capital Partners's RPTP Position: Q4 2016 in Review

GSA Capital Partners sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 22,152 shares — an estimated $199K sold.

GSA Capital Partners first reported a position in RPTP in Q4 2015 and held it in 2 quarters. The position peaked at $199K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

GSA Capital Partners reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
GSA Capital Partners sold 22,152 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $199K.
GSA Capital Partners first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2015 and held it in 2 quarters.
GSA Capital Partners's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $199K in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on GSA Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.